Veru (VERU) to Release Quarterly Earnings on Wednesday

Veru (NASDAQ:VERU) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter.

Veru (NASDAQ:VERU) last released its earnings results on Monday, April 1st. The company reported ($0.09) earnings per share for the quarter. Veru had a negative return on equity of 257.92% and a negative net margin of 405.04%. The firm had revenue of $2.14 million during the quarter. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Veru Stock Performance

Shares of VERU opened at $1.47 on Thursday. The company’s 50 day moving average price is $0.89 and its 200 day moving average price is $0.79. Veru has a 52 week low of $0.36 and a 52 week high of $1.92. The company has a market capitalization of $215.19 million, a PE ratio of -2.03 and a beta of -0.48.

Wall Street Analysts Forecast Growth

Several research firms recently commented on VERU. Oppenheimer reiterated an “outperform” rating and set a $5.00 target price (down from $7.00) on shares of Veru in a research note on Monday, April 15th. Raymond James began coverage on shares of Veru in a research report on Thursday, March 28th. They set an “outperform” rating and a $3.00 target price on the stock. Finally, HC Wainwright restated a “buy” rating and set a $2.00 target price on shares of Veru in a report on Thursday, February 8th.

Veru Company Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.